NCT04377659 2025-05-28
Tocilizumab for Prevention of Respiratory Failure in Patients With Severe COVID-19 Infection
Memorial Sloan Kettering Cancer Center
Phase 2 Terminated
Memorial Sloan Kettering Cancer Center
University of Edinburgh
Poitiers University Hospital
Singapore General Hospital
M.D. Anderson Cancer Center
Centre d'Investigation Clinique et Technologique 805
M.D. Anderson Cancer Center